Lilly To Increase Investment In Chongqing
This article was originally published in PharmAsia News
Executive Summary
Eli Lilly officials recently visited Chongqing to seek market expansion. The firm has been forging a long-term collaboration with local medical institutions and colleges particularly in diabetes, where it will increase investment in areas such as public education, welfare services and academic exchange. It plans to add at least 800 employees in China and double the staff number in Chongqing to make it the top revenue generator in south-west China. Lilly is optimistic about Chongqing thanks to the latter's substantial strength in healthcare and talent. In addition, the city leads the push to implement urban-rural integrated medical insurance, which covers more patients, making it attractive to pharmaceutical companies. (Click here for more - Chinese Language)